CURT LABELLE

Profile

First Name

: CURT

Middle Name

:

Last Name

: LABELLE

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
SAFEOP SURGICAL, INC.
EUGENE CATTARINA, MARK D-ADDATO, TSONTCHO IANCHULEV, CHRISTOPHER KREDIET, RICHARD O-BRIEN, NEIL RYAN, ROB SNOW, JAMES L.L. TULLIS
DIRECTOR
EXAGEN DIAGNOSTICS INC
KAMAL ADAWI, JOHN P. ALSOBROOK, II, JOHN BESSONE, DAVID BILVIN, BRIAN BIRK, DAVID BLIVIN, DANIEL C. BURRELL, LISA DAVIS, THIERRY DERVIEUX, SCOTT GLENN, SCOTT L. GLENN, MARK HAZELTINE, CURTIS LABELLE, BETO PALLARES, EBETUEL PALLARES, DINESH PATEL, JOHN M. RADAK, SAM RICCITELLI, FORTUNATO R. ROCCA, RON ROCCA, STEPHANIE SPONG, TODD STEVENS, WENDY SWEDICK, JAMES L.L. TULLIS, WANETA C. TUTTLE, MICHAEL WALSH, MICHAEL J. WALSH, ARTHUR WEINSTEIN, FRANK WITNEY
DIRECTOR
KUROBE PHARMACEUTICALS, INC.
BARRY BUTLER, HALEY BUTLER, YVONNE GALLIMORE, SEAN IANCHULEV, EIJI KATAYAMA, NAOHITO TAKAHASHI
EXECUTIVE OFFICER, DIRECTOR
EYENOVIA, INC.
BARRY BUTLER, FRED ESHELMAN, FREDRIC ESHELMAN, JOHN GANDOLFO, MICHAEL GELTZEILER, TSONTCHO IANCHULEV, RACHEL JACOBSON, HYUNSU JUNG, KENNETH LEE, ERNEST MARIO, CHARLES MATHER, MICHAEL ROWE, ELLEN STRAHLMAN, ANTHONY SUN, SHUHEI YOSHIDA
DIRECTOR
INPRESS TECHNOLOGIES, INC.
ANNE MORRISSEY, SHACEY PETROVIC, FRED ST. GOAR, PHYLLIS WHITELEY
DIRECTOR
REVELATION BIOSCIENCES, INC
JENNIFER CARVER, JAMES M. ROLKE, JESS ROPER, GEORGE F. TIDMARSH, CHESTER S. ZYGMONT, CHESTER S. ZYGMONT III
DIRECTOR
OPHIREX, INC.
HANS BISHOP, TIMOTHY GARNETT, JEREMIAH HARRISON, NANCY J. KOCH, MATTHEW R. LEWIN, DERRICK ROSSI
DIRECTOR
CXL OPHTHALMICS, INC.
SUSAN MACDONALD, MARC ODRICH, EDWARD PARSONS, JONATHAN TALAMO, MICHAEL WEBB
DIRECTOR
VEDANTA BIOSCIENCES, INC.
BHARATT CHOWRIRA, DANIEL COUTO, SUSAN DILLON, MARTIN HEIDECKER, TROY IGNELZI, JOHN LAMATTINA, JOHN L LAMATTINA, JOHN L. LAMATTINA, MARK MULLIKIN, BERNAT OLLE, BENNETT SHAPIRO, BENNETT M SHAPIRO, BENNETT M. SHAPIRO, CHARLES SHERWOOD, JEFFREY SILBER, NEIL TIWARI, CHRISTOPHER VIEHBACHER
DIRECTOR
RESOLUTE RESOURCES LTD./CAN
NEIL BOTHWELL, PAUL COLLENS, ALEXANDER LINDSAY, KIERNAN LYNCH, BRADLEY PARKES, CHRIS WOLFENBERG
DIRECTOR
NOVOCUFF, INC.
AMELIA DEGENKOLB, LILLY DESOUZA BURR, DONALD LEE, SHACEY PETROVIC, REBECCA SHMUKLER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-08-05
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2023-03-01 
2024-07-17
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-04 
2023-06-20
D
Link
OIL AND GAS 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-06 
2023-05-02
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2023-03-01 
2022-10-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-28 
2022-03-28
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-16 
2021-05-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-01-04 
2021-04-23
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-01-29 
2021-04-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-01-29 
2020-04-07
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-03-24 
2018-08-28
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-17 
2017-08-14
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-07 
2016-08-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2016-07-19 
2015-04-01
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Debt 
2015-02-19 
2014-07-29
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-14 
2014-07-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-07-10 
2013-10-15
D
Link
BIOTECHNOLOGY 
 
$5,000,001 - $25,000,000 
Equity 
2013-10-04 
2013-06-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-21 
2012-11-01
D
Link
BIOTECHNOLOGY 
 
$1,000,001 - $5,000,000 
Equity 
2012-10-18 
2012-09-11
D
Link
BIOTECHNOLOGY 
 
$1,000,001 - $5,000,000 
Equity 
2012-09-04 
2012-01-31
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2012-01-04